Trials / Withdrawn
WithdrawnNCT01682434
Wavefront-guided LASIK for Correction of Myopia
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Aarhus University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Laser in situ keratomileusis is a successful procedure for the treatment of low to moderate myopia. Advances over the last decade have allowed LASIK to also correct higher order wavefront aberrations. In low myopia, there seem to be a minor effect of such wavefront-guided treatment. However, it remains to be established whether there is a beneficial effect in higher degrees of myopia. The study aims to determine whether myopic subjects (-6 to -10 diopters) with higher-than-average preoperative higher-order aberrations have benefit of wavefront-guided treatment. Subjects are randomized to wavefront-guided treatment in one eye, and conventional treatment in the other.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Laser in situ keratomileusis (LASIK) | Wavefront guided treatment in one eye, conventional in the other. |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2014-01-01
- First posted
- 2012-09-11
- Last updated
- 2014-05-02
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01682434. Inclusion in this directory is not an endorsement.